EnLiSense Limited Liability Company
Background
EnLiSense LLC, established in 2014, is a medical technology company specializing in the development of wearable diagnostic devices and biosensors for health monitoring. The company's mission is to provide innovative solutions for chronic disease management and wellness, focusing on personalized healthcare through the analysis of biomarkers in sweat and other body fluids. EnLiSense is headquartered in Allen, Texas, United States.
Key Strategic Focus
EnLiSense's strategic focus centers on the creation of point-of-care diagnostic devices and solutions, particularly those utilizing sweat-based diagnostics. The company specializes in the development of wearable devices capable of monitoring various health markers, including glucose, cortisol, interleukins, proBNP, cardiovascular biomarkers, and troponins. These devices aim to assist clinicians and patients in managing chronic diseases and promoting overall wellness.
Financials and Funding
EnLiSense has raised a total of $240,000 over four funding rounds. The most recent funding occurred on April 12, 2023, through an incubator/accelerator program, with IBD Ventures as the investor. Prior funding includes a business plan competition on April 10, 2019, and a grant from the National Institutes of Health on September 1, 2017.
Pipeline Development
EnLiSense has developed several key pipeline candidates, including:
- CORTI: A wearable device designed to monitor daily stress patterns, sleep/wake cycles, and support wellness routines. The trademark application for CORTI was filed on August 18, 2025.
- SWEAT AWARE: A wearable device intended to sense sweat and monitor inflammatory diseases for medical purposes. The trademark for SWEAT AWARE was registered on August 26, 2025.
- IBD AWARE: A wearable device aimed at monitoring inflammatory bowel diseases through sweat analysis. The trademark for IBD AWARE was registered on October 8, 2024.
Technological Platform and Innovation
EnLiSense's technological platform is centered around the development of wearable diagnostic devices that utilize biosensing technology to analyze biomarkers in sweat and other body fluids. The company's proprietary technologies include sensors for measuring biometric data and hormone levels, as well as electric sensors for scientific use. These innovations enable continuous health monitoring and personalized healthcare solutions.
Leadership Team
- Sriram: Co-Founder & CEO with 23 years of experience in the medical device industry.
- Vikram Narayanan Dhamu: Director & Head of Systems & Operations, bringing 11 years of experience in systems engineering and operations management.
- Jayanth Karnam: Thin Film Process Engineer with 19 years of experience in process engineering and development.
- Crisvin Kadambathil: Hardware and Firmware Engineer with 6 years of experience in hardware design and firmware development.
Competitor Profile
The wearable health monitoring market is experiencing significant growth, driven by increasing health awareness and the demand for personalized healthcare solutions. Advancements in biosensing technologies and the integration of artificial intelligence are enhancing the capabilities of wearable devices.
Key competitors in the wearable health monitoring space include Seer, Artera, and BioAgilytix Labs. These companies focus on developing advanced biosensors and diagnostic platforms for health monitoring. The competitive landscape is characterized by rapid technological advancements and the need for regulatory compliance in medical device development.
Strategic Collaborations and Partnerships
EnLiSense has engaged in strategic collaborations to enhance its product development and market reach. Notably, the company received funding from the National Institutes of Health in 2017, supporting its research and development efforts.
Operational Insights
EnLiSense's operational strategy focuses on the development of innovative wearable diagnostic devices that offer continuous health monitoring and personalized healthcare solutions. The company's competitive advantages include its proprietary biosensing technologies, a strong leadership team with extensive industry experience, and strategic collaborations that support its product development initiatives.
Strategic Opportunities and Future Directions
EnLiSense is well-positioned to capitalize on the growing demand for wearable health monitoring devices. Future opportunities include expanding its product portfolio to address a broader range of health conditions, enhancing the integration of artificial intelligence for data analysis, and exploring international markets to increase its global presence.
Contact Information
- Website: enlisense.com
- Social Media: LinkedIn
- Headquarters: Allen, Texas, United States
